Advanced Search

 

Study ID Status Title Patient Level Data
FNM30015 Completed A dose-ranging, parallel-group study comparing fluticasone propionate aqueous nasal spray 50mcg, 100mcg, 200mcg and 400mcg twice daily with placebo in patients with perennial rhinitis.
FNM30016 Completed A single-centre, randomised, double-blind, parallel group study to determine the efficacy and tolerability of fluticasone propionate aqueous nasal spray 200µg twice daily, beclomethasone dipropionate aqueous nasal spray 200µg twice daily and placebo aqueous nasal spray administered twice daily i ...
FNM30019 Completed Fluticasone propionate aqueous nasal spray 200mcg once daily vs. 100mcg twice daily in ragweed allergic rhinitis in a multicentre, double-blind, placebo-controlled, parallel group study.
FNM30020 Completed A double-blind, placebo-controlled, parallel group comparative study to assess the safety and efficacy of fluticasone propionate aqueous nasal spray, 200mcg given once daily, with beclomethasone dipropionate aqueous nasal spray, 200mcg given twice daily, in the treatment of seasonal rhinitis.
FNM30021 Completed A double-blind, parallel-group study to assess the safety of long-term use of fluticasone propionate aqueous nasal spray (200mcg given twice daily) compared with beclomethasone dipropionate aqueous nasal spray (200mcg given twice daily) in the treatment of perennial rhinitis.
FNM30024 Completed Fluticasone propionate aqueous nasal spray, 200mcg twice daily, versus beclomethasone dipropionate aqueous nasal spray, 200mcg twice daily, in seasonal rhinitis. A multicentre, placebo-controlled, double-blind, parallel-group study.
FNM30029 Completed A parallel group comparison of fluticasone propionate aqueous nasal spray (FPANS) with placebo in patients with non-seasonal allergic rhinitis with symptoms all year round.
FNM30030 Completed A Double-Blind, Double-Dummy, Randomized, Parallel Group Comparison of 200mcg Fluticasone Propionate Aqueous Nasal Spray, Placebo and 10mg Encapsulated Loratadine Administered (No More than Once Daily) As-Needed in Subjects with Seasonal Allergic Rhinitis
FNM30031 Completed A Double-Blind, Double-Dummy, Randomized, Parallel Group Comparison of 200mcg Fluticasone Propionate Aqueous Nasal Spray, Placebo and 10mg Encapsulated Loratadine Administered (No More than Once Daily) As-Needed in Subjects with Seasonal Allergic Rhinitis
FNM30033 Completed A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy of a Four-week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on Ocular Systems Commonly Associated with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM30034 Completed A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy of a Four-Week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on Ocular Symptoms Commonly Associated with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM40001 Completed A multi-centre, randomised, double blind, placebo controlled, parallel group study examining the effect of fluticasone propionate aqueous nasal spray (200mcg od) and/or inhaled fluticasone propionate (250mcg bd) in pollen induced asthma and rhinits.
FNM40017 Completed A Multi-Center, Randomized, Double-Blind, Parallel Gruop Study to Assess the Potential Growth Effects of a One-year Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) versus Placebo in Pre-pubescent, Pediatric Subjects with Perennial Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM40027 Completed Intranasal fluticasone propionate 200?g once daily versus 200?g twice daily in severe ragweed allergic rhinitis.
FNM40030 Completed Fluticasone propionate aqueous nasal spray treatment for perennial allergic rhinitis in children.
FNM40044 Completed A study to investigate the effect of intranasal fluticasone propionate in more detail during nasal allergen provocation in patients with an isolated grass pollen allergy.Extensive searching has see citation below.
FNM40054 Completed A placebo controlled trial during the pollen season comparing the effects of intranasal beclomethasone dipropionate and fluticasone propionate in children and young adults with asthma and allergic rhinitis.Extensive searching has revealed that no clinical report is available for this study.
FNM40071 Completed A double-blind, double-dummy, parallel-group trial: fluticasone once daily versus loratadine once daily in pollinic rhinitis
FNM40072 Completed Intranasal Fluticasone Once Daily Compared with Once-Daily Cetirizine in the Treatment of Seasonal Allergic Rhinitis.Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
FNM40079 Completed A study to investigate the effect of intranasal fluticasone propionate in more detail during nasal allergen provocation in patients with an isolated grass pollen allergy.Extensive searching has revealed that no clinical report is available for this study.
FNM40083 Completed Intranasal fluticasone proprionate does not prevent acute otitis media during viral upper respiratory infection in children.Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
FNM40108 Completed Continuous therapy with fluticasone-nasal spray (200mg) versus oral cetirizine (10mg) in patients with seasonal allergic rhinitis: Comparison of effects of a pre- and coseasonal treatment on symptoms, quality of life and cytokines and mediators in nasal secretion.
FNM40123 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of fluticasone propionate aqueous 200mcg QD versus beclomethasone aqueous 168mcg BID versus placebo by intranasal administration for two weeks in adult patients with seasonal allergic rhinitis in the mountain cedar s ...
FNM40137 Completed The common cold: Effects of intranasal fluticasone propionate treatment.Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
FNM40138 Completed Intranasal fluticasone propionate vs. beclomethasone dipropionate in the treatment of adult patients with perennial allergic rhinitis. A multi-centre, randomized, double-blind, parallel-group study.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.